{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:16:06Z","timestamp":1792250166934,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":1980,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1124\/dmd.119.086959","type":"journal-article","created":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:45:30Z","timestamp":1557535530000},"page":"854-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3481-8201","authenticated-orcid":false,"given":"Matthew D.","family":"Harwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7813-3442","authenticated-orcid":false,"given":"Mian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-8890","authenticated-orcid":false,"given":"Shriram M.","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-1960","authenticated-orcid":false,"given":"Sibylle","family":"Neuhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.086959_bib1","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.2337\/db10-1740","article-title":"GLUT2 accumulation in enterocyte apical and intracellular membranes: a study in morbidly obese human subjects and ob\/ob and high fat-fed mice","volume":"60","author":"Ait-Omar","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/dmd.119.086959_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.bcp.2005.06.018","article-title":"Expression of the drug transporters MDR1\/ABCB1, MRP1\/ABCC1, MRP2\/ABCC2, BCRP\/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver","volume":"70","author":"Albermann","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1021\/mp0600687","article-title":"Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine","volume":"4","author":"Berggren","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.086959_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ibd.20088","article-title":"Decreased P-glycoprotein (P-gp\/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels","volume":"13","author":"Blokzijl","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/dmd.119.086959_bib5","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1124\/dmd.111.042465","article-title":"Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines","volume":"40","author":"Bourgine","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/bdd.2025","article-title":"Caco-2 cells\u2014expression, regulation and function of drug transporters compared with human jejunal tissue","volume":"38","author":"Br\u00fcck","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.119.086959_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1124\/dmd.116.071183","article-title":"Abundance of hepatic transporters in Caucasians: a meta-analysis","volume":"44","author":"Burt","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cell.2015.07.022","article-title":"A call for systematic research on solute carriers","volume":"162","author":"C\u00e9sar-Razquin","year":"2015","journal-title":"Cell"},{"key":"10.1124\/dmd.119.086959_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/cpt.419","article-title":"Ibrutinib dosing strategies based on interaction potential of CYP3A4 perpetrators using physiologically based pharmacokinetic modeling","volume":"100","author":"de Zwart","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cpt.967","article-title":"Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"104","author":"Drozdzik","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib11","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.086959_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejps.2006.04.010","article-title":"Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with caco-2 cells","volume":"29","author":"Englund","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.086959_bib13","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-associated changes in drug transporters may impact the pharmacokinetics and\/or toxicity of drugs: a white paper from the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters","volume":"157","author":"Fromm","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/dmd.119.086959_bib15","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1124\/dmd.110.032649","article-title":"Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data","volume":"38","author":"Gertz","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.119.086959_bib17","doi-asserted-by":"crossref","first-page":"C846","DOI":"10.1152\/ajpcell.00112.2005","article-title":"Expression and membrane localization of MCT isoforms along the length of the human intestine","volume":"289","author":"Gill","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/dmd.119.086959_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.crohns.2011.08.003","article-title":"Expression and functional analysis of intestinal organic cation\/L-carnitine transporter (OCTN) in Crohn\u2019s disease","volume":"6","author":"Girardin","year":"2012","journal-title":"J Crohn\u2019s Colitis"},{"key":"10.1124\/dmd.119.086959_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC-MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Gr\u00f6er","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.086959_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/cpt.1183","article-title":"Advancing predictions of tissue and intracellular drug concentrations using in vitro, imaging and physiologically based pharmacokinetic modeling approaches","volume":"104","author":"Guo","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/mol.112.084517","article-title":"Organic cation transporter 1 (OCT1\/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes","volume":"84","author":"Han","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib22","unstructured":"Harwood MD (2015) Towards a fully mechanistic prediction of oral drug absorption: investigating intestinal transporter abundance and function relationships. Ph.D. thesis, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK."},{"key":"10.1124\/dmd.119.086959_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpba.2015.02.043","article-title":"Application of an LC-MS\/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique","volume":"110","author":"Harwood","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/dmd.119.086959_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/bdd.1810","article-title":"Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption","volume":"34","author":"Harwood","year":"2013","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.119.086959_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/prca.201400147","article-title":"The role of quantitative ADME proteomics to support construction of physiologically based pharmacokinetic models for use in small molecule drug development","volume":"9","author":"Heikkinen","year":"2015","journal-title":"Proteomics Clin Appl"},{"key":"10.1124\/dmd.119.086959_bib26","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1208\/ps030109","article-title":"Spatial expression patterns of peptide transporters in the human and rat gastrointestinal tracts, Caco-2 in vitro cell culture model, and multiple human tissues","volume":"3","author":"Herrera-Ruiz","year":"2001","journal-title":"AAPS PharmSci"},{"key":"10.1124\/dmd.119.086959_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib29","first-page":"2401","article-title":"Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas","volume":"6","author":"Hinoshita","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/dmd.119.086959_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/gut.2005.067389","article-title":"Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis","volume":"55","author":"Hruz","year":"2006","journal-title":"Gut"},{"key":"10.1124\/dmd.119.086959_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40262-013-0097-y","article-title":"A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine","volume":"53","author":"Jamei","year":"2014","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.119.086959_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1208\/s12248-009-9099-y","article-title":"Population-based mechanistic prediction of oral drug absorption","volume":"11","author":"Jamei","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.086959_bib33","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1124\/dmd.111.042994","article-title":"Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data","volume":"40","author":"Jones","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt.37","article-title":"Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective","volume":"97","author":"Jones","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib35","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.xphs.2017.04.001","article-title":"The organic anion-transporting peptide 2B1 is localized in the basolateral membrane of the human jejunum and caco-2 monolayers","volume":"106","author":"Keiser","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.086959_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.phrs.2007.06.005","article-title":"Comparative gene expression profiles of intestinal transporters in mice, rats and humans","volume":"56","author":"Kim","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1124\/dmd.119.086959_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-230X-12-78","article-title":"Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia","volume":"12","author":"Kleberg","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1124\/dmd.119.086959_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.103.051300","article-title":"Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane","volume":"306","author":"Kobayashi","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.086959_bib39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.103.051011","article-title":"Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters","volume":"306","author":"Landowski","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.086959_bib40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/dmd.106.013342","article-title":"Regional distribution of solute carrier mRNA expression along the human intestinal tract","volume":"35","author":"Meier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib41","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1124\/dmd.116.072140","article-title":"Extrapolation of elementary rate constants of P-glycoprotein-mediated transport from MDCKII-hMDR1-NKI to caco-2 cells","volume":"45","author":"Meng","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/dmd.116.072157","article-title":"Microvilli morphology can affect efflux active P-glycoprotein in confluent MDCKII -hMDR1-NKI and caco-2 cell monolayers","volume":"45","author":"Meng","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib43","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1073\/pnas.0304987101","article-title":"Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney","volume":"101","author":"Mikkaichi","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/dmd.119.086959_bib44","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/acs.molpharmaceut.6b00085","article-title":"Quantitative atlas of cytochrome P450, UDP-glucuronosyltransferase, and transporter proteins in jejunum of morbidly obese subjects","volume":"13","author":"Miyauchi","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.086959_bib45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"M\u00fcller","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib46","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/pmic.201500433","article-title":"Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: comparison with MRM\/SRM and HR-MRM\/PRM","volume":"16","author":"Nakamura","year":"2016","journal-title":"Proteomics"},{"key":"10.1124\/dmd.119.086959_bib47","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/jps.23594","article-title":"Application of permeability-limited physiologically-based pharmacokinetic models: part I-digoxin pharmacokinetics incorporating P-glycoprotein-mediated efflux","volume":"102","author":"Neuhoff","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.119.086959_bib48","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1208\/s12248-013-9521-3","article-title":"Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters","volume":"15","author":"Oswald","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.086959_bib49","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0022-3565(24)37149-6","article-title":"Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism","volume":"283","author":"Paine","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 7","key":"10.1124\/dmd.119.086959_bib50","first-page":"S122","article-title":"The application of physiologically based pharmacokinetic modeling to predict the role of drug transporters: scientific and regulatory perspectives","volume":"56","author":"Pan","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib51","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1124\/dmd.107.015743","article-title":"Disparity in holoprotein\/apoprotein ratios of different standards used for immunoquantification of hepatic cytochrome P450 enzymes","volume":"35","author":"Perrett","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/00498250310001646353","article-title":"Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors","volume":"34","author":"Proctor","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.119.086959_bib53","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1194\/jlr.M800162-JLR200","article-title":"Reduced ileal expression of OST\u03b1-OST\u03b2 in non-obese gallstone disease","volume":"49","author":"Renner","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1124\/dmd.119.086959_bib54","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.106.009530","article-title":"Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal caco-2 cells","volume":"34","author":"Sai","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib55","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejps.2006.03.003","article-title":"Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells","volume":"28","author":"Seithel","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.119.086959_bib56","doi-asserted-by":"crossref","first-page":"27473","DOI":"10.1074\/jbc.M301106200","article-title":"Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OST\u03b1-OST\u03b2","volume":"278","author":"Seward","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.119.086959_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/cpt.1013","article-title":"Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective","volume":"104","author":"Shebley","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib58","doi-asserted-by":"crossref","first-page":"G1586","DOI":"10.1152\/ajpgi.00457.2006","article-title":"Protein-protein interactions and membrane localization of the human organic solute transporter","volume":"292","author":"Sun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.119.086959_bib59","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.bcp.2005.09.027","article-title":"Expression profiles of various transporters for oligopeptides, amino acids and organic ions along the human digestive tract","volume":"70","author":"Terada","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib60","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1053\/j.gastro.2007.08.041","article-title":"Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation","volume":"133","author":"Thibault","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.119.086959_bib61","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bcp.2011.10.017","article-title":"Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum","volume":"83","author":"Tucker","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.119.086959_bib62","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.116.072231","article-title":"Regional expression levels of drug transporters and metabolizing enzymes along the pig and human intestinal tract and comparison with Caco-2 cells","volume":"45","author":"Vaessen","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib63","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1007\/s11095-012-0792-7","article-title":"Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions","volume":"29","author":"Varma","year":"2012","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.086959_bib64","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40262-014-0188-4","article-title":"Predicting the effect of cytochrome P450 inhibitors on substrate drugs: analysis of physiologically based pharmacokinetic modeling submissions to the US Food and Drug Administration","volume":"54","author":"Wagner","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.119.086959_bib65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/2050640613505279","article-title":"Fructose transporters GLUT5 and GLUT2 expression in adult patients with fructose intolerance","volume":"2","author":"Wilder-Smith","year":"2014","journal-title":"United European Gastroenterol J"},{"key":"10.1124\/dmd.119.086959_bib66","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1021\/acs.jproteome.5b00523","article-title":"Absolute proteome analysis of colorectal mucosa, adenoma, and cancer reveals drastic changes in fatty acid metabolism and plasma membrane transporters","volume":"14","author":"Wi\u015bniewski","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1124\/dmd.119.086959_bib67","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/dmd.109.027367","article-title":"Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients","volume":"37","author":"Wojtal","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib68","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/dmd.118.080424","article-title":"Application of physiologically based pharmacokinetic modeling in understanding bosutinib drug-drug interactions: importance of intestinal P-glycoprotein","volume":"46","author":"Yamazaki","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.086959_bib69","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/cpt.1112","article-title":"Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance","volume":"104","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.086959_bib70","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ajcn\/75.5.922","article-title":"Distribution of the H+\/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome","volume":"75","author":"Ziegler","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1124\/dmd.119.086959_bib71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1124\/dmd.104.001354","article-title":"Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract","volume":"33","author":"Zimmermann","year":"2005","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624078231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.086959","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:24:09Z","timestamp":1739957049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624078231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0090955624078231"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.086959","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Regional-Specific Relative and Absolute Expression of Gut Transporters in Adult Caucasians: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.086959","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}